P1110: REAL-WORLD TREATMENT PATTERNS OF BRUTON TYROSINE KINASE INHIBITORS (BTKI) IN PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) IN COMMUNITY ONCOLOGY PRACTICES IN THE UNITED STATES (US)

• Bijal Shah,
• Mei Xue,
• Keri Yang,
• Sizhu (Tom) Liu,
• Boxiong Tang

Affiliations

Bijal Shah

1 Moffitt Cancer Center, Tampa, United States

Mei Xue

2 BeiGene USA, Inc., San Mateo, United States

Keri Yang

2 BeiGene USA, Inc., San Mateo, United States

Sizhu (Tom) Liu

3 Formerly with BeiGene USA, Inc., San Mateo, United States

Boxiong Tang

2 BeiGene USA, Inc., San Mateo, United States